Literature DB >> 29669112

A critical appraisal of the sensitivity of in vivo genotoxicity assays in detecting human carcinogens.

Andreas Zeller1, Stefan Pfuhler2, Silvio Albertini1, Frank Bringezu3, Andreas Czich4, Yasmin Dietz4, Rolf Fautz5, Nicola J Hewitt6, Annette Kirst5, Peter Kasper7.   

Abstract

Genotoxicity testing is an important part of standard safety testing strategies. Animal studies have always been a key component, either as a mandatory part of the regulatory test battery, or to follow-up questionable in vitro findings. The strengths and weaknesses of in vivo assays is a continuous matter of debate, including their capacity to predict (human) carcinogenicity. We have therefore analysed the sensitivity of five routinely used in vivo tests to determine, in addition to other aspects, which tests or combination of tests best identify 73 chemicals classified as IARC Group 1 and 2A carcinogens. The in vivo tests included the micronucleus (MN), unscheduled DNA synthesis (UDS), comet, Pig-a and transgenic rodent assays (TGR). The individual assays detect 74.2% (49/66, MN), 64.3% (9/14, UDS), 92.1% (35/38, comet), 82.4% (14/17, Pig-a) and 90.3% (28/31, TGR) of the probable and confirmed human carcinogens that were tested in these assays. Combining assays that cover different genotoxicity endpoints and multiple tissues, e.g. the bone marrow MN and the liver comet assays, increases the sensitivity further (to 94%). Correlations in terms of organ-specificity for these assays with human cancer target organs revealed only a limited correlation for the hematopoietic system but not for other organs. The data supports the use of the comet and TGR assays for detection of 'site-of-first-contact' genotoxicants, but these chemicals were generally also detected in assays that measure genotoxicity in tissues not directly exposed, e.g. liver and the hematopoietic system. In conclusion, our evaluation confirmed a high sensitivity of the five in vivo genotoxicity assays for prediction of human carcinogens, which can be further increased by combining assays. Moreover, the addition of the comet to the in vivo MN test would identify all DNA reactive human carcinogens. Importantly, integration of some of the study readouts into one experiment is an animal-saving alternative to performing separate experiments.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29669112     DOI: 10.1093/mutage/gey005

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  7 in total

Review 1.  Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide.

Authors:  John Nicolette; Mirjam Luijten; Jennifer C Sasaki; Laura Custer; Michelle Embry; Roland Froetschl; George Johnson; Gladys Ouedraogo; Raja Settivari; Veronique Thybaud; Kerry L Dearfield
Journal:  Environ Mol Mutagen       Date:  2021-11-22       Impact factor: 3.579

2.  Preliminary Evidence for a Hormetic Effect on DNA Nucleotide Excision Repair in Veterans with Gulf War Illness.

Authors:  Jean J Latimer; Abdullah Alhamed; Stefanie Sveiven; Ali Almutairy; Nancy G Klimas; Maria Abreu; Kimberly Sullivan; Stephen G Grant
Journal:  Mil Med       Date:  2020-02-13       Impact factor: 1.437

3.  No Genotoxicity Is Detectable for Escherichia coli Strain Nissle 1917 by Standard In Vitro and In Vivo Tests.

Authors:  Silke Dubbert; Birgit Klinkert; Michael Schimiczek; Trudy M Wassenaar; Rudolf von Bünau
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2020-03-17

4.  Molnupiravir Does Not Induce Mutagenesis in Host Lung Cells during SARS-CoV-2 Treatment.

Authors:  John Maringa Githaka
Journal:  Bioinform Biol Insights       Date:  2022-03-23

Review 5.  Molnupiravir and Its Antiviral Activity Against COVID-19.

Authors:  Lili Tian; Zehan Pang; Maochen Li; Fuxing Lou; Xiaoping An; Shaozhou Zhu; Lihua Song; Yigang Tong; Huahao Fan; Junfen Fan
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 7.561

Review 6.  Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review.

Authors:  Kalpana Ramanna Mali; Madhavi Eerike; Gerard Marshall Raj; Debasis Bisoi; Rekha Priyadarshini; Gandham Ravi; Leo Francis Chaliserry; Siddharam S Janti
Journal:  Ir J Med Sci       Date:  2022-09-10       Impact factor: 2.089

7.  APC gene 3'UTR SNPs and interactions with environmental factors are correlated with risk of colorectal cancer in Chinese Han population.

Authors:  Rongbiao Ying; Zhiping Wei; Yuxian Mei; Shasha Chen; Liming Zhu
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.